Satyavrat Shukla

Satyavrat Shukla

Chief Executive Officer chez SPERO THERAPEUTICS, INC.

Fortune : - $ au 31/03/2024

52 ans
Health Technology
Consumer Services
Commercial Services

Profil

Satyavrat Shukla is currently the President, Chief Executive Officer & Director at Spero Therapeutics, Inc. He previously worked as the Vice President & Global Head-Corporate Finance at Vertex Pharmaceuticals, Inc. from 2012 to 2019.
Before that, he was a Principal at Cornerstone Research, Inc. from 2003 to 2012.
In 2019, he served as the Chief Financial Officer & Executive Vice President at Alaunos Therapeutics, Inc. Mr. Shukla completed his undergraduate degree at Harvard University in 1993 and obtained an MBA from Yale University in 1999.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
08/03/2024 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Satyavrat Shukla

SociétésPosteDébut
SPERO THERAPEUTICS, INC. Chief Executive Officer 01/08/2023
Tous les postes actifs de Satyavrat Shukla

Anciens postes connus de Satyavrat Shukla

SociétésPosteFin
ALAUNOS THERAPEUTICS, INC. Director of Finance/CFO 31/12/2020
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 01/07/2019
Corporate Officer/Principal 01/01/2012
Voir l'expérience en détail de Satyavrat Shukla

Formation de Satyavrat Shukla

Harvard University Undergraduate Degree
Yale University Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Satyavrat Shukla

Relations

100 +

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

ALAUNOS THERAPEUTICS, INC.

Health Technology

SPERO THERAPEUTICS, INC.

Health Technology

Entreprise privées1

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Satyavrat Shukla